Daratumumab Market Share, Size, Analysis, Growth, Industry Statistics and Forecast 2034
Daratumumab Market Overview
A monoclonal antibody called daratumumab that targets CD38 has become a transformational treatment for a variety of hematologic malignancies, most notably multiple myeloma (MM). The treatment of relapsed/refractory MM and newly diagnosed patients who are not eligible for transplant has been revolutionized by its exceptional efficacy, both when used alone and in...
0 Commentarii
0 Distribuiri
959 Views
Chinese
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Portuguese (Brazil)
Greek